Skip to main content
logo
Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
6.57
-0.02 (-0.30%)
Aug 26, 2026, 12:58 PM EDT - Market open

Prelude Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
67723997323287577
Market Cap Growth
616.79%147.03%-70.04%12.32%-50.21%-80.97%
Enterprise Value
543202-399365259
Last Close Price
6.592.901.274.276.0412.45

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
30.2719.6813.82---
PB Ratio
5.073.480.741.361.472.02
P/TBV Ratio
5.083.480.741.361.472.02

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
24.2916.63----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.130.260.140.070.010.01
Net Debt / Equity Ratio
-1.00-1.25-0.88-0.91-1.02-1.01
Net Debt / EBITDA Ratio
2.080.840.841.651.642.57
Net Debt / FCF Ratio
4.031.521.121.952.303.37
Asset Turnover
0.150.080.03---
Quick Ratio
3.991.955.2110.679.3015.17
Current Ratio
4.071.995.3010.799.4215.37
Return on Equity (ROE)
-57.73%-99.45%-69.01%-56.34%-47.97%-44.85%
Return on Assets (ROA)
-27.15%-40.74%-38.54%-33.19%-29.38%-26.89%
Return on Capital Employed (ROCE)
-43.70%-116.90%-93.20%-51.70%-62.10%-39.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-8.91%-41.64%-131.47%-37.74%-40.16%-19.35%
FCF Yield
-4.90%-23.59%-107.16%-34.25%-30.18%-14.87%
Buyback Yield / Dilution
-10.91%-1.52%-25.60%-27.41%-2.87%-269.03%
SEC Filings: 10-K · 10-Q